Why is Injective price up today?

Traders Union
All News
Crypto News
Injective surges 10.31% today to $5.28

Highlights

Injective's entry into the U.S. regulated crypto futures market has drawn significant institutional interest, supporting ongoing adoption.
Pineapple Financial now holds over 7.5 million INJ in treasury and continues accumulating via open-market purchases.
INJ/USD trades with strong bullish momentum above support at $4.74, but overbought conditions signal likely consolidation between $4.74 and $6.09 near-term.

Institutional demand grows as Injective enters regulated US futures market

Injective recently entered the U.S. regulated crypto futures market, which has stimulated institutional interest and is expected to support broader adoption. Pineapple Financial Inc. disclosed holdings of over 7.5 million INJ tokens in its treasury and continues accumulating additional INJ through regular open-market purchases. Increased investor participation and positive network activity have also been observed.

Anton Kharitonov, expert at Traders Union, believes INJ’s technical setup is strong but warns of rising overbought risks. He sees the price above all key moving averages and positive momentum indicators, yet notes that the rally may have run ahead of underlying fundamentals. Kharitonov points to the low probability of further upside, especially with key weekly signals not confirming a breakout. Institutional interest and network activity support the trend, but he remains vigilant about a potential pullback below $4.74. "Traders should be cautious and avoid chasing price at current levels — overextension and lack of fresh buy signals mean risk of correction remains elevated."

Viktoras Karapetjanc, expert at Traders Union, sees ongoing institutional accumulation and regulatory expansion as key drivers for Injective’s growth. He highlights rising treasury holdings and strong network participation as signs of increasing adoption. With the bullish structure above major moving averages, the analyst expects further market setups to emerge. "INJ remains a top opportunity as positive momentum and institutional demand align — further growth is likely if buyers hold the $4.74 support."

Uptrend sustained as technical signals warn of overbought risk

INJ/USD is decisively above its 20-day ($4.39), 50-day ($3.66), and 200-day ($4.32) moving averages, indicating short-, medium-, and long-term bullish momentum. The Ichimoku Kijun at $4.75 now acts as dynamic support, with the next likely resistance around the recent high or at the $5.50 round level. Momentum indicators such as the Moving Average Convergence Divergence (MACD) and Average Directional Index (ADX) confirm strong upward momentum. The Relative Strength Index (RSI) at 61 signals ongoing buying interest, while the Stochastic RSI and Commodity Channel Index (CCI) suggest overbought conditions are developing. Bull/Bear Power (BBP) above zero shows buyer dominance, and its overbought reading heightens the risk of pullback. The Awesome Oscillator supports the uptrend. INJ/USD jumped 10.31% on a decisive upside gap, with the current price near the daily high and intraday volatility at 11.25%. The intraday tone reflects strong buying pressure into the close. Oscillators and momentum indicators confirm bullish strength for now, despite some short-term overbought signals.

Earlier, analysts noted that Injective was exhibiting strong bullish momentum with expectations for near-term consolidation. The latest developments—including institutional accumulation and entry into the U.S. futures market—strengthen this outlook, making sustained closes above $6.09 the key trigger for any breakout beyond the current consolidation zone.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.